Many studies have demonstrated that milk protein consumption has benefits in terms of promoting human health. This review assesses the intervention studies which have evaluated potential health enhancing effects in humans following the ingestion of milk proteins. The impact of milk protein ingestion has been studied to asses their satiating, hypotensive, antimicrobial, anti-inflammatory, anticancer, antioxidant, insulinotropic properties as well as their impact on morphological modifications (e.g., muscle and fat mass) in humans. Consistent health promoting effects appear to have been observed in certain instances (i.e., muscle protein synthesis, insulinotropic and hypotensive activity). However, controversial outcomes have also been reported (i.e., antimicrobial, antiinflammatory, anticancer and antioxidant properties). Several factors including interindividual differences, the timing of protein ingestion as well as the potency of the active components may explain these differences. In addition, processing conditions have been reported, in certain instances, to affect milk protein structure and therefore modify their bioactive potential. It is thought that the health promoting properties of milk proteins are linked to the release of bioactive peptides (BAPs) during gastrointestinal digestion. There is a need for further research to develop a more in-depth understanding on the possible mechanisms involved in the observed physiological effects. In addition, more carefully controlled and appropriately powered human intervention studies are required to demonstrate the health enhancing properties of milk proteins in humans.
Introduction
fragments, also known as bioactive peptides (BAPs), have been shown in vitro to positively 7 affect markers associated, for instance, with inflammation, hypertension, diabetes and 8 osteoporosis [41, 52, 66, 96] . These BAPs may be released during gastrointestinal (GI) digestion 9 of milk proteins in humans [15] . Several studies have reported that milk protein-derived BAPs 10 may also play a beneficial in vivo role in humans [for reviews: see 7, 51, 84, 100]. 11
To date, most studies in humans appear to have been conducted with hydrolysed milk proteins 12 while intact milk proteins may also have some potential in human health [76] . studies have failed to demonstrate health promoting effects following milk protein consumption 18 [48, 103] . 19 The aim of this review was to specifically investigate the potential link between milk protein 20 consumption and their health promoting effects in humans. Therefore, human intervention 21 studies which have been conducted with milk proteins were studied for a wide range of bioactive 22 (i.e., satiating, hypotensive, antimicrobial, anti-inflammatory, anticancer, antioxidant and 23 insulinotropic and muscle protein synthesis) properties. The outcomes of these human 24 intervention studies as well as the parameters (e.g., dose, duration, health status of the subjects, 25 etc.) which generally yielded health enhancement were studied. The scientific literature related to 26 the bioactive properties of milk proteins in humans was assessed for the time period ranging 27 from 1985 to 2015. Current evidence on the release of BAP sequences following milk protein 28 ingestion in humans was collated. The impact of processing on milk protein structure and the 29 effect on the bioactivity was also assessed to better understand how these may modulate peptide 30 release and in turn impact on human health. 31
Satiating and weight management effects of milk proteins in

humans
33
It has been suggested that a significant increase in protein intake, over habitual intake, could help 34 in weight management and positively alter body composition [2, 77, 128]. Significant differences 35 in anthropometric parameters were reported in healthy and obese humans when the protein 36 concentration in the test group was on average 58.4% (g/kg/day) higher than in the control 37 group. In contrast, no effect on food intake was observed with differences of up to 38.8% 38 (g/kg/day) between the test and control groups [14] . Milk proteins, which have been described 39 for their satiating properties, may have potential for use as natural dietary components to reduce 40 food intake in humans [2, 36, 77, 115, 128] . Numerous human intervention studies have focused 41 on the satiating properties of milk proteins and their effect on the reduction of food intake [for 42
reviews: see 13, 77] . A strong link between protein intake and weight loss has been suggested, 43
highlighting the role of their texturizing properties, amino acid composition and rate of 44 absorption in increasing satiety. However, to date, a direct link between satiety and food intake 45 reduction followed by weight loss has proved difficult to establish in humans. 46
Owing to differences between the rate of digestion, amino acid and peptide appearance in the 47 plasma, whey proteins (WPs) have been postulated as being more satiating than caseins (CNs). A 48 faster gastric emptying for WPs compared to CNs has been shown [2] . Differences were found 49 with intact CN solutions, which showed a slower rate of intestinal absorption compared to the 50 WPs [22] . This was linked to the fact that part of the CN may coagulate at the acidic gastric pH, 51 thereby delaying CN protein breakdown [56] . On a time scale basis, it has been suggested that 52
WPs are more satiating in the short term and CN in the long term [13] . 53 Table 1 summarizes the outcomes of human intervention studies conducted with intact milk 54 proteins. A positive role of WPs in reducing food intake has been shown in human studies 55 involving obese subjects [9, 122] . Recently, a 12 week study was conducted with obese subjects 56 with a body mass index (BMI) between 25 and 40 kg m -2 who received a preload of whey protein 57 concentrate (WPC, 65 g) before an ad libitum meal [122] . At the end of the intervention, there 58 To date, most studies which have investigated the effects of milk protein intake on hypertension 150 have been conducted in adults. The effect of skim milk, WP or CN (35 g/day for 12 weeks) 151 intake on BP has recently been investigated in obese adolescents [5] . No effect on SBP and 152 arterial stiffness could be seen at the end of the dietary intervention. However, reductions in DBP 153 of -1.8 and -2.2 mm Hg in the CN and the control group, respectively, were reported. 154
The hypotensive effects reported in certain studies may be linked to the release of angiotensin 155 converting enzyme (ACE) inhibitory peptides in the GIT of humans following the ingestion of 156 milk proteins (Table 2 ). In summary, dietary intervention studies with milk proteins have only 157
shown a modest reduction in SBP and DBP or no effect. The largest effect seen (-8.6 and -8.0 158 mm Hg in DBP and SBP, respectively) was observed with pre-hypertensive subjects who 159 received 28 g WPC80/day for 6 weeks. These effects may be similar to those previously seen 160 with ACE inhibitory lactotripeptides (LTPs -i.e., Ile-Pro-Pro and Val-Pro-Pro), also reporting 161 higher hypotensive effects in human subjects having a higher basal BP [for reviews, see: 39, 162 100]. 163
Antimicrobial role of milk proteins in humans
164
Particular attention has to date been given to lactoferrin (LF), a minor WP, as it is able in its 165 intact format to display antimicrobial activities. The mechanisms involved are thought to relate 166 to binding to the lipopolysaccharide membrane of microorganisms. LF has been shown to induce 167 membrane disruption, to penetrate into dendritic cells, to sequester iron and to display prebiotic 168 activities preventing pathogen growth [17, 24, 50, 90, 118, 123] . 169
Several human studies are found in the literature evaluating the antimicrobial properties of intact 170 LF [104] . A human recombinant LF solution (600 mL at 5 mg mL -1 ) was administered via 171 gastrostomy tubes for 56 days to nursing-home residents at the start of an antibiotic treatment 172
[70]. This resulted in a decreased incidence of antibiotic-associated diarrhea, which has in certain 173 instances been linked with the presence of Clostridium difficile. Diarrhea was seen with 44% of 174 the subjects receiving the LF solution as opposed to 92% in the control group administered with 175 a placebo. Bovine LF has also been used as an adjunct in the triple therapy against Helicobacter 176 pylori in randomized control trials (RCTs) [ have been identified in the GIT of humans following milk protein intake (Table 2) . Therefore, 218 these may have potential to act at least at the gut level as anti-inflammatory/immunomodulatory 219 agents. To date, the anti-inflammatory properties of milk proteins appear to have mainly been 220 studied in the context of obesity in humans. Overall, the results on the anti-inflammatory 221 properties in humans caused by the ingestion intact milk proteins appear to be inconclusive. 222
While some effects were reported in a post-prandial study on markers of low-grade 223 inflammation, others studies have failed in demonstrating a benefit of milk protein consumption 224 on the inflammatory status of overweight subjects. 225
Anticancer effects of milk proteins in humans
226
The majority of studies demonstrating the anticancer activity of milk proteins appear to have 227 been carried out with LF. In the context of colorectal cancer, for example, a study was conducted 228 in 104 participants (40-75 y) with polyps ≤ 5 mm diameter [67] . Bovine LF was supplemented 229 for a 12 month period at a daily intake of 1.5 (60.25) or 3 (60.5) g. Overall, there was no 230 significant effect of LF on polyp growth. However, the 3 g bovine LF intake significantly 231 retarded colorectal adenomatous polyp growth in subjects  63 y, with a higher effect being 232 . In acute human studies, it was suggested that WPs had a higher 296 insulinotropic activity than CN, owing to their faster rate of digestion [94, 95] . However, in 297 certain studies conducted with type 2 diabetic subjects, no significant differences between WP 298 and CN ingestion were evidenced on insulin secretion and serum glucose levels [91] . 299
WPs (55 g) ingestion 30 min before or during a high carbohydrate meal by type 2 diabetic 300 subjects led to an increase in insulin secretion and a reduction in glycaemia [78] . Other studies 301 also showed that supplementation of a high carbohydrate lunch with 27. shown that both the pH and matrix structure affected the kinetics of peptide release. Acid gels 419 were digested more rapidly than liquid milk, followed by rennet gels. The effect of pH was 420 explained by the fact that acid gels had a pH value closer to that of the optimum pH for pepsin 421 (2.0) while liquid milk may have slowed down pepsin activity through its buffering capacity. In 422 the case of rennet gels, their compact structure may have limited the access of digestive enzymes 423
It is generally accepted that the structure of milk proteins affects their digestibility in humans 425 [45, 79, 126] . In particular, the rate of nitrogen release from whey products has been reported to 426 be faster than that of CN due to differences in the gastric emptying for both proteins. However, 427 this is only observed with micellar CN as processed CN has lost its ability to form micelles 428 [126] . The effect of the dairy matrix structure on the kinetics of digestion has recently been 429 studied in a model of gastric emptying [74] . The kinetics of digestion was shown to be mostly 430 influenced by the rate of gastric emptying, which was governed by the matrix structure. [69]. The rate of protein digestion and therefore nitrogen incorporation in the plasma was higher 436 with UHT than pasteurized and microfiltered milks. 437
In summary, the effect of processing on milk proteins is often studied from a nutritional point of 438 view. However, processing also has major implications on the bioaccessibility (i.e., release of 439 peptides in the intestinal lumen) of milk proteins, which can affect their bioactive properties in 440
humans. This stresses the importance of evaluating milk proteins in the final food product in 441 which they will be incorporated in order to properly assess their potential health enhancing 442
properties. 443 
Conclusions
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